Free Cash Flow for Pfizer (PFE)
Free Cash Flow for Pfizer (PFE): headline value $9.08B · YoY -7.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
PFE
Currently viewingFree Cash FlowSwitch metric
Latest period
$9.08B
YoY change
-7.7%
5Y CAGR
-4.8%
Peak year (2021)
$29.87B
Latest annual
$9.08B
Free Cash Flow history chart for Pfizer (PFE) from 1989 to 2025
Free Cash Flow history table for Pfizer (PFE) from 1989 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $9.08B | -7.7% | ||
| 2024 | $9.84B | +105.2% | ||
| 2023 | $4.79B | -81.6% | ||
| 2022 | $26.03B | -12.8% | ||
| 2021 | $29.87B | +157.2% | ||
| 2020 | $11.61B | +16.2% | ||
| 2019 | $9.99B | -26.7% | ||
| 2018 | $13.63B | -4.4% | ||
| 2017 | $14.25B | +2.5% | ||
| 2016 | $13.90B | +6.8% | ||
| 2015 | $13.02B | -14.9% | ||
| 2014 | $15.30B | -6.1% | ||
| 2013 | $16.30B | +3.6% | ||
| 2012 | $15.73B | -15.4% | ||
| 2011 | $18.58B | +86.9% | ||
| 2010 | $9.94B | -35.4% | ||
| 2009 | $15.38B | -7.0% | ||
| 2008 | $16.54B | +44.1% | ||
| 2007 | $11.47B | -26.2% | ||
| 2006 | $15.54B | +23.1% | ||
| 2005 | $12.63B | -8.1% | ||
| 2004 | $13.74B | +51.0% | ||
| 2003 | $9.10B | +8.0% | ||
| 2002 | $8.43B | +19.3% | ||
| 2001 | $7.06B | +76.3% | ||
| 2000 | $4.00B | +167.8% | ||
| 1999 | $1.50B | -13.6% | ||
| 1998 | $1.73B | +152.3% | ||
| 1997 | $686.00M | -46.9% | ||
| 1996 | $1.29B | +14.9% | ||
| 1995 | $1.13B | +37.7% | ||
| 1994 | $817.00M | +29.9% | ||
| 1993 | $628.80M | +373.5% | ||
| 1992 | $132.80M | -47.7% | ||
| 1991 | $253.80M | -18.9% | ||
| 1990 | $313.00M | +57.0% | ||
| 1989 | $199.30M | — |
Free Cash Flow values are taken from Pfizer's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Pfizer (PFE) most recent annual free cash flow stands at $9.08B (2025) – declined 7.7% year-over-year.
Through 2020–2025 (5 years), Pfizer free cash flow delivered a -4.8% annualised rate; with a net decline across the window.
Pfizer free cash flow peaked at $29.87B in 2021; the latest annual figure is $9.08B in 2025 (69.6% below peak).
The dataset's maximum free cash flow sits at $29.87B (2021); the minimum reading of $132.80M dates to 1992.
Pfizer (PFE) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of $14.22B.
Pfizer Free Cash Flow by Year
Pfizer Free Cash Flow 2025: $9.08B
Pfizer free cash flow in 2025 was $9.08B, declined 7.7% below 2024.
Pfizer Free Cash Flow 2024: $9.84B
Pfizer free cash flow in 2024 was $9.84B, surged 105.2% from 2023.
Pfizer Free Cash Flow 2023: $4.79B
Pfizer free cash flow in 2023 was $4.79B, plunged 81.6% below 2022.
Pfizer Free Cash Flow 2022: $26.03B
Pfizer free cash flow in 2022 was $26.03B, declined 12.8% below 2021.
Pfizer Free Cash Flow 2021: $29.87B
Pfizer free cash flow in 2021 was $29.87B.
See more financial history for Pfizer (PFE).
Sector peers — Free Cash Flow
Companies in the same sector as Pfizer, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is Pfizer's free cash flow?
Latest reported free cash flow for Pfizer (PFE) is $9.08B (period ending December 31, 2025).
How has Pfizer free cash flow changed year-over-year?
Pfizer (PFE) free cash flow changed -7.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Pfizer free cash flow?
Pfizer (PFE) free cash flow compound annual growth rate is -4.8% over the most recent 5 years available.
When did Pfizer free cash flow hit its highest annual value?
Pfizer free cash flow reached its highest annual value of $29.87B in 2021.
What was Pfizer free cash flow in 2024?
Pfizer (PFE) free cash flow in 2024 was $9.84B.
What was Pfizer free cash flow in 2025?
Pfizer (PFE) free cash flow in 2025 was $9.08B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
PFE Overview
Company profile, financial tools, and key metrics
PFE Revenue Counter
Earns $1,984 every second. See per minute, hour, and day.
PFE Earnings Counter
Earns $246.39 per second net profit. See per minute, hour, and day.
PFE Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
PFE What If Invested
What if you had invested $1,000? See historical returns from any date.
PFE How It Makes Money
Discover visual breakdown of $62.58B in revenue — where it comes from and where it goes.
PFE Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PFE Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PFE Daily Price Character
Steady · 46.3% historical win rate (green days). Streaks & record days.
PFE Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
PFE Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
PFE Dividend Profile
Yield: 6.55%. Safety: 3/8. See full history.
PFE Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
PFE Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.